1.0
OBJECTIVE:
To
describing the procedure for defining the role and responsibility of Quality
Unit.
2.0
SCOPE:
This
SOP is applicable for defining the responsibility of Quality Assurance and
Quality Control department.
3.0
RESPONSIBILITY:
All
Staff – QA
All
Staff – QC
Head–
Quality
4.0
PROCEDURE:
4.1
Principle:
4.1.1
The holder of a Manufacturing
Authorization must manufacture medicinal products so as to ensure that they are
fit for their intended use, comply with the requirements of marketing
Authorization and do not place patients at risk due to inadequate safety,
quality or efficacy.
4.1.2
The attainment of the quality
objective is the responsibility of plant management and requires the
participation and commitment by staff in all departments and at all levels.
4.2
Quality Unit comprises of two
department i.e. Quality Assurance department and Quality Control department.
4.3
Quality Assurance:
4.3.1
QA is a wide-ranging concept
that covers all matters that individually or collectively influence the quality
of a product.
4.4
Quality Control:
4.4.1
QC is that part of GMP which is
concerned with sampling, specifications, testing, organization, documentation
and release procedure which ensures that the relevant tests are carried out and
materials are not released until the quality has been found to be satisfactory.
4.5
Responsibilities of Quality
Assurance Department:
4.5.1
To ensure presence of quality
policy and quality manual.
4.5.2
Preparation of Validation
Master Plan.
4.5.3
Preparation of Site Master
File.
4.5.4
Preparation of Annual Product
quality Review.
4.5.5
Handling of Market complaints,
return goods and product recalls.
4.5.6
Qualification of Vendors
4.5.7
To conduct self-audits as per
defined schedule.
4.6
Material Management:
4.6.1
To ensure procedure for indent,
receipt, storage and issuance of material as per defined procedure and cGMP
requirements.
4.6.2
Verification of Finished
Product Dispatches
4.6.3
Medicinal products are not sold
or supplied before certification that each batch has been produced in
accordance with the requirements of Marketing Authorization and any other
regulations relevant to production, control and release of medicinal products.
4.6.4
Satisfactory arrangements to
ensure that medicinal products are stored, distributed and subsequently handled
so that quality is maintained throughout their shelf-life;
4.7
Process Control:
4.7.1
Review, approval and rejection
of change controls.
4.7.2
Review, approval and rejection
of incidents.
4.7.3
Review, approval and rejection
of deviations.
4.7.4
Preparation, Review and
approvals of Qualifications (DQ, URS IQ, OQ, PQ)
4.7.5
Preparation, Review and
approval of Process validations.
4.7.6
In-process checking of products
and line clearance.
4.7.7
Review and approval of failure
investigations.
4.7.8
Review and approval of
reprocessing and rework.
4.7.9
Approval of online rejections
and material return notes
4.7.10 Review and approval of Manufacturing Instructions.
4.7.11 Storage and recording of control samples.
4.7.12 Review and approval of CAPA.
4.7.13 Review and approval of artworks and shade cards.
4.7.14 Arrangements are made for the manufacture, supply and use of the
correct starting and packaging materials.
4.7.15 Medicinal products are designed and developed in a way that takes
account of the requirements of GMP and GLP.
4.8
Training:
4.8.1
Induction Training
4.8.2
SOP training and on job
training
4.8.3
CGMP training.
4.8.4
Training related to quality
management system.
4.8.5
Contract worker training
4.8.6
External Trainings
4.9
Document and Data Control:
4.9.1
To retain master copy of all
the documents.
4.9.2
To issue and retrieve
controlled copy of the master documents.
4.9.3
To issue Un-controlled copy of
the master documents.
4.9.4
To issue and retrieve log
books.
4.9.5
To Prepare, review approval and
revision of SOPs of QA department and approval of SOPs of other department.
4.10
Batch Release Function:
4.10.1 Prepare Review and approval of BMR and BPR.
4.10.2 To issue BMR/BPR.
4.10.3 Review of BMR/BPR and raw data sheet before release.
4.10.4 Review of COA.
4.10.5 Approval of batch through QA batch release intimation slip.
4.11
Audit and Compliance:
4.11.1 To conduct Self-Inspection or quality audit, this regularly
appraises the effectiveness and applicability of QA system.
4.11.2 To prepare audit reports and monitor compliances
4.11.3 To prepare for external (regulatory and customer) audits.
4.11.4 To prepare responses to external audits and monitor compliances.
4.12
Equipment Management:
4.12.1 To ensure usage of only qualified equipment for production.
4.12.2 To ensure calibration of equipments and instruments as per plan.
4.13
New Product Introduction:
4.13.1 To ensure analytical method validation, specification and STP,
stability protocol, cleaning validation method, master formulation record,
product specification, batch manufacturing record and batch packing record
before starting new product.
4.14
Product Identification and
Traceability:
4.14.1 Batch numbering system.
4.14.2 Unique identifying system for incoming material.
4.14.3 Traceability of Material during production.
4.14.4 Labeling procedure.
4.14.5 Equipment coding and status labeling.
4.15
Purchasing:
4.15.1 Approved vendor and supplier listing.
4.16
Third Party Jobs:
4.16.1 Audit of outside labs for analytical testing.
4.17
Annual Product Quality Review:
4.17.1 Regular periodic review of all licensed medicinal products should be
conducted with the objective of verifying the consistency of existing process,
the appropriateness of current specifications.
4.17.2 Such reviews should normally be conducted and documented, and should
include at least:
·
Review of starting and
packaging material used for the products;
·
Review of finished product
results;
·
Review of all batches that
failed to meet established specifications and their investigation;
·
Review of all significant
deviations or incidents, their related investigations, and effectiveness of
resultant CAPA taken;
·
Review of all changes carried
out to the processes or analytical methods;
·
Review of all quality-related
returns, complaints and recalls and the investigations performed at the time;
·
The qualification status of
relevant equipment and utilities.
·
Review of technical agreements
to ensure that they are up to date.
4.18
GMP for Medicinal Products:
4.18.1 The basic requirement of GMP are that
·
All manufacturing
process are clearly defined, and shown to be capable of consistently
manufacturing medicinal products complying with their specification;
·
Critical steps and
changes in process are validated;
·
All necessary
facilities for GMP are provided including:
·
Qualified and trained
personnel;
·
Adequate premises and
space;
·
Suitable equipment and
services;
·
Correct materials,
containers, labels;
·
Approved procedures and
instructions;
·
Suitable storage and
transport;
·
Instructions and
procedures are written in an instructional form in clear and unambiguous
language, specifically applicable to the facilities provided;
·
Records are made,
manually or by recording instruments, during manufacture that demonstrate that
all steps defined in procedure, quantity and are in fact taken. Any significant
deviation is recorded and investigated;
·
Records of manufacture
enable the complete history of a batch record to be traced, are retained in
accessible form;
·
A system is available
to recall any batch of product, from sale or supply;
·
Complaints about
marketed products are examined, causes are investigated and appropriate
measures are taken to prevent reoccurrence.
4.19
Responsibilities of Quality
Control Department:
4.19.1 The basic requirements of QC are:
·
Adequate facilities,
trained personnel and approved procedures are available for sampling,
inspection and testing starting materials, packaging materials, intermediate,
bulk and FP;
·
Test methods are
validated;
·
Records are made,
manually or by recording instruments, which demonstrate that sampling,
inspection and testing procedure were actually carried out. Any significant
deviation is recorded and investigated.
·
FP contains active
ingredients complying with the qualitative and quantitative composition of
marketing Authorization, are of purity required, and enclosed in proper
container with correct labels.
·
Records are made of
results of inspection and testing of materials, intermediate, bulk and finished
products is formally assessed against specification.
4.19.2 Good Laboratory Practices and Equipments:
·
Ensure that lab carry out its
testing, calibration, validation, and all other technical activities in such a
way as to meet GLP requirements.
4.19.3 Premises:
The laboratory shall
be designed, constructed and maintained so as to:
·
Prevent entry of
insects and rodents besides cross contamination;
·
Interior surface shall
be smooth and free from cracks and permit easy cleaning and sanitization;
·
Provision made for the
space, equipment and also for utilities like water, power and gas; air
ventilation system;
·
Table top shall be
constructed with alkali, acid and solvent resistant material and shall be
smooth and free from cervices as far as possible;
4.19.4 Personal:
·
Staff in lab shall
possess necessary qualification, proper training and shall have adequate
experience for the assigned duties.
·
Ensuring the control
and maintenance of documents including the quality system as per the
requirements of regulatory authorities which involve all raw data, SOP’s,
documentation protocols, etc.
4.19.5 Equipments:
·
Instruments requiring
calibration shall be calibrated at regular intervals and records shall be
maintained.
·
The instruments,
instrument bench and surroundings areas shall be kept clean and tidy all the
times.
·
Glassware such as
burettes, pipettes and volumetric flasks shall be calibrated. Weight boxes and
thermometers etc. shall also be calibrated.
·
Autoclaves must meet
the requirements described for operations, safety and validation procedure.
·
Work involving the
evolution of harmful and obnoxious vapors shall be carried out in a fume hood.
4.19.6 Chemicals and Reagents:
·
The storage and
handling of chemicals and reagents shall be done in a manner considering the
physiochemical properties of these substances and hazards involved in their
use.
·
All reagents and
solutions shall be identified with a label.
·
Containers of stock
solutions and standard solution should bear name of analytical chemist who
prepared the solution, date of preparation, use before date and strength of
solution.
4.19.7 Good housekeeping and safety:
·
Standard Operating
Procedures for safety, house-keeping shall be prepared in accordance with
various rules, and regulations of Government of India and include the following
requirements;
·
Drinking, eating and
smoking shall not be permitted in the laboratories; food for human consumption
shall not be kept in working or storage areas;
·
Staff must wear
laboratory coats or other protective clothing including gloves and mask;
·
The laboratories shall
have firefighting equipments and eye washer. Protective precautions to be taken
in Laboratories
·
Safety Shower shall be
installed;
·
Rubber suction bulbs
must be used on pipettes; Appropriate facilities for the collection, storage,
and disposal of wastes shall be made available;
·
Staff must be aware of
methods for safe disposal of corrosive or dangerous products;
·
A standard operating
procedure for handling, collection, disposal of chemical and biological wastes
be prepared.
·
Maintenance,
calibration and validation of all instruments, equipments and other devices
used in laboratory.
·
Reference materials are
necessary for testing, calibration, validation and verification of a sample or
of equipment or other devices and all such materials shall be traceable to
agency authorized by Government of India or any other international body.
·
The laboratory shall
prepare working standards by comparing with the reference standards and shall
be routinely checked for their purity.
·
Standard Operating
Procedure for maintenance of microbial culture and sub-culture must be prepared
by the laboratories. All activities are carried out under Laminar Airflow.
·
Raw data refers to the
laboratory worksheet, note books or analysis sheet, records, memorandum, notes
or extract copies that may be results of observations and other activities
shall be maintained. Data integrity and security shall be maintained and data
shall not be accessible to any unauthorized person.
5.0
ANNEXURE(S):
Nil
6.0
REFERENCES:
NIL
7.0
ABBREVIATION(S):
SOP Standard Operating procedure
QA Quality Assurance
QC Quality Control
GMP Good manufacturing practices
cGMP Current Good manufacturing practices
DQ Design Qualification
URS User Requirement Specifications
IQ Installation Qualification
OQ Operational Qualification
PQ Performance Qualification
CAPA Corrective and preventive Action
GLP Good Laboratory Practices
STP Standard testing Procedure
COA Certificate of Analysis
BMR Batch manufacturing record
BPR Batch packaging record
FP Finished Product
8.0
DISTRIBUTED TO:
Quality
Assurance
Quality
Control
9.0
REVISION HISTORY:
Revision No.
|
Change Control No.
|
Reason for the Modifications
|
|
|
|
No comments:
Post a Comment